|
Reference
|
Author
|
Year
|
Metastasis
|
Adjuvant chemotherapy
|
With palliative gastrectomy
|
Without palliative gastrectomy
|
1-year survival
|
3-year survival
|
5-year survival
|
Follow-up(month)
|
HR (95%CI)
|
|---|
|
Patients number
|
Median survival time (month)
|
Ptaients number
|
Median survival time (month)
|
with PG
|
without PG
|
with PG
|
without PG
|
with PG
|
without PG
|
|---|
|
1
|
Kikuchi S [26]
|
1998
|
M1
|
-
|
63
|
12.2
|
59
|
5.5
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
40
|
0.55 (0.35,0.85)
|
|
2
|
Saidi RF [27]
|
2006
|
M0 + M1
|
±
|
24
|
13.2
|
81
|
5.5
|
NA
|
NA
|
NA
|
NA
|
5%
|
0
|
60
|
0.46 (0.03,7.2)
|
|
3
|
Nazli O [28]
|
2007
|
M0
|
-
|
21
|
8
|
39
|
3
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
36
|
NA
|
|
4
|
Lin SZ [29]
|
2008
|
M0 + M1
|
±
|
183
|
NA
|
206
|
NA
|
61.3%
|
1.3%
|
8.9%
|
0
|
6.2%
|
0
|
60
|
0.61 (0.45,0.82)
|
|
5
|
Lupascu C [30]
|
2010
|
M0 + M1
|
±
|
30
|
17.8
|
45
|
6.4
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
30
|
0.78 (0.06,9.64)
|
|
6
|
Zhang JZ [31]
|
2011
|
M0 + M1
|
-
|
184
|
16.4
|
152
|
5.5
|
51.4%
|
0
|
NA
|
NA
|
NA
|
NA
|
60
|
0.64 (0.49,0.84)
|
|
7
|
Sougioultzis S [32]
|
2011
|
M0 + M1
|
+
|
218
|
13.25
|
93
|
4
|
NA
|
NA
|
8.1%
|
3.5%
|
NA
|
NA
|
75
|
0.08 (0.06,0.13)
|
|
8
|
Kim KH [33]
|
2011
|
M1
|
+
|
47
|
15.5
|
185
|
9
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
60
|
0.65 (0.45,0.94)
|
|
9
|
Chang YR [34]
|
2011
|
M1
|
±
|
108
|
12.7
|
57
|
11.2
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
60
|
0.59 (0.42,0.89)
|
|
10
|
Kokkola A [35]
|
2012
|
M1
|
±
|
23
|
10.8
|
32
|
5.7
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
60
|
0.99 (0.5,1.94)
|
|
11
|
Chen S [36]
|
2012
|
M0 + M1
|
±
|
392
|
NA
|
470
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
48
|
0.71 (0.58,0.87)
|
|
12
|
Tokunaga M [37]
|
2012
|
M1
|
±
|
82
|
13.1
|
66
|
12
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
60
|
1.03 (0.65,1.65)
|
|
13
|
Miki Y [38]
|
2012
|
M1
|
±
|
38
|
25.6
|
12
|
8.7
|
64.4%
|
36.7%
|
36.1%
|
12.2%
|
29.4%
|
0
|
83
|
0.27 (0.12,0.59)
|
|
14
|
Dittmar Y [39]
|
2012
|
M0 + M1
|
±
|
48
|
15
|
45
|
6
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
60
|
0.56 (0.32,0.99)
|
|
Total publications: 14
| | | |
1461
|
14.96*
|
1542
|
7.07*
| | | | | | | | |
- +: all patients received chemotherapy. -: chemotherapy was not mentioned. ±: a part of patients received chemotherapy.
- *: weighted average of median survival time of articles.
